Mark Rothera's Net Worth
$4.66 Million
Who is Mark Rothera?
Mark Rothera has an estimated net worth of $4.66 Million. This is based on reported shares across multiple companies, which include PTC THERAPEUTICS, INC., Orchard Therapeutics plc, Viracta Therapeutics, Inc., and Aegerion Pharmaceuticals, Inc..
SEC CIK
Mark Rothera's CIK is 0001550424
Past Insider Trading and Trends
2015 was Mark Rothera's most active year for acquiring shares with 15 total transactions. Mark Rothera's most active month to acquire stocks was the month of December. 2015 was Mark Rothera's most active year for disposing of shares, totalling 21 transactions. Mark Rothera's most active month to dispose stocks was the month of August. 2015 saw Mark Rothera paying a total of $4,211,243.60 for 139,766 shares, this is the most they've acquired in one year. In 2015 Mark Rothera cashed out on 113,216 shares for a total of $4,101,356.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $26.79
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.30% | 2K |
$10.85 | $21,700.00 | 33.74K |
May 24
| |||
Form 4
| +10.31% | 2.97K |
$10.85 | $32,181.10 | 31.74K |
Mar 15
| |||
Form 4
| +12.18% | 3.13K |
$10.85 | $33,906.25 | 28.77K |
Feb 16
| |||
Form 4
| +13.87% | 3.13K |
$10.85 | $33,906.25 | 25.65K |
Jan 17
| |||
Form 4
| +74.29% | 9.6K |
—
|
—
| 22.52K |
Jan 3
| |||
Form 4
| +20.93% | 1.94K |
$10.85 | $21,059.85 | 11.22K |
Nov 14
| |||
Form 4
| +26.62% | 1.95K |
$10.85 | $21,157.50 | 9.28K |
Oct 10
| |||
Form 4
| +42.93% | 2.2K |
$10.85 | $23,870.00 | 7.33K |
Sep 26
| |||
Form 4
| +64.00% | 2K |
$6.23 | $12,460.00 | 5.13K |
Mar 3
| |||
Form 4
|
∞
| 3.13K |
$10.85 | $33,906.25 | 3.13K |
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 9.22K |
$10.85 | $99,993.60 | 9.22K |
Jul 21
| |||
Form 4
|
—
|
0
|
$43.75 | -$703,953.00 |
0
|
Scheduled
|
Mar 17
| ||
Form 4
|
—
|
0
|
$43.61 | -$19,653.00 |
0
|
Scheduled
|
Mar 13
| ||
Form 4
| -100.00% | -3.00K |
$39.43 | -$2,033,200.00 |
0
|
Scheduled
|
Feb 23 - Feb 25
| ||
Form 4
| -50.00% | -3.00K |
$60.02 | -$180,060.00 | 3K |
Scheduled
|
Jan 20
| ||
Form 4
|
—
|
0
|
$34.76 | -$109,986.00 | 6K |
Scheduled
|
Jan 16
| ||
Form 4
| -33.33% | -3.00K |
$34.45 | -$490,304.00 | 6K |
Scheduled
|
Jan 13 - Jan 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| -47.06% | -8.00K |
$27.74 | -$627,359.00 | 9K |
Scheduled
|
Sep 24 - Sep 26
| ||
Form 4
| -32.00% | -8.00K |
$36.24 | -$289,909.60 | 17K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
∞
| 25K |
$15.00 | $375,000.00 | 25K |
May 15 - Jun 25
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Orchard Therapeutics plc (ORTX) No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viracta Therapeutics, Inc. (VIRX) Snapshot price: $0.586
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
∞
| 100K |
$0.49 | $49,361.68 | 100K |
Nov 30 - Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aegerion Pharmaceuticals, Inc. No price found
Global President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||